Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 19 |
NetGPI | no | yes: 0, no: 19 |
Related structures:
AlphaFold database: E9AW62
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 20 |
GO:0005488 | binding | 1 | 20 |
GO:0036094 | small molecule binding | 2 | 20 |
GO:0097159 | organic cyclic compound binding | 2 | 20 |
GO:1901265 | nucleoside phosphate binding | 3 | 20 |
GO:1901363 | heterocyclic compound binding | 2 | 20 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 155 | 157 | PF00675 | 0.336 |
CLV_NRD_NRD_1 | 348 | 350 | PF00675 | 0.369 |
CLV_NRD_NRD_1 | 59 | 61 | PF00675 | 0.248 |
CLV_PCSK_KEX2_1 | 155 | 157 | PF00082 | 0.374 |
CLV_PCSK_KEX2_1 | 330 | 332 | PF00082 | 0.410 |
CLV_PCSK_PC1ET2_1 | 330 | 332 | PF00082 | 0.309 |
CLV_PCSK_PC7_1 | 326 | 332 | PF00082 | 0.312 |
CLV_PCSK_SKI1_1 | 125 | 129 | PF00082 | 0.315 |
CLV_PCSK_SKI1_1 | 155 | 159 | PF00082 | 0.450 |
CLV_PCSK_SKI1_1 | 195 | 199 | PF00082 | 0.331 |
CLV_PCSK_SKI1_1 | 283 | 287 | PF00082 | 0.360 |
DEG_APCC_DBOX_1 | 194 | 202 | PF00400 | 0.342 |
DOC_PP4_FxxP_1 | 203 | 206 | PF00568 | 0.390 |
DOC_PP4_FxxP_1 | 289 | 292 | PF00568 | 0.398 |
DOC_USP7_MATH_1 | 193 | 197 | PF00917 | 0.161 |
DOC_USP7_MATH_1 | 221 | 225 | PF00917 | 0.301 |
DOC_USP7_MATH_1 | 252 | 256 | PF00917 | 0.254 |
DOC_USP7_MATH_1 | 348 | 352 | PF00917 | 0.479 |
DOC_WW_Pin1_4 | 108 | 113 | PF00397 | 0.392 |
DOC_WW_Pin1_4 | 163 | 168 | PF00397 | 0.508 |
DOC_WW_Pin1_4 | 248 | 253 | PF00397 | 0.413 |
LIG_14-3-3_CanoR_1 | 155 | 160 | PF00244 | 0.419 |
LIG_14-3-3_CanoR_1 | 349 | 353 | PF00244 | 0.402 |
LIG_APCC_ABBAyCdc20_2 | 125 | 131 | PF00400 | 0.246 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.521 |
LIG_Clathr_ClatBox_1 | 127 | 131 | PF01394 | 0.308 |
LIG_deltaCOP1_diTrp_1 | 188 | 197 | PF00928 | 0.337 |
LIG_deltaCOP1_diTrp_1 | 346 | 352 | PF00928 | 0.457 |
LIG_FHA_1 | 269 | 275 | PF00498 | 0.401 |
LIG_FHA_1 | 3 | 9 | PF00498 | 0.502 |
LIG_FHA_1 | 352 | 358 | PF00498 | 0.373 |
LIG_FHA_2 | 64 | 70 | PF00498 | 0.281 |
LIG_FHA_2 | 85 | 91 | PF00498 | 0.319 |
LIG_GBD_Chelix_1 | 209 | 217 | PF00786 | 0.325 |
LIG_IRF3_LxIS_1 | 51 | 57 | PF10401 | 0.155 |
LIG_LIR_Apic_2 | 288 | 292 | PF02991 | 0.352 |
LIG_LIR_Gen_1 | 196 | 205 | PF02991 | 0.369 |
LIG_LIR_Gen_1 | 66 | 71 | PF02991 | 0.317 |
LIG_LIR_Gen_1 | 77 | 85 | PF02991 | 0.296 |
LIG_LIR_Nem_3 | 188 | 194 | PF02991 | 0.317 |
LIG_LIR_Nem_3 | 319 | 325 | PF02991 | 0.397 |
LIG_LIR_Nem_3 | 66 | 70 | PF02991 | 0.317 |
LIG_LIR_Nem_3 | 77 | 83 | PF02991 | 0.296 |
LIG_MYND_1 | 178 | 182 | PF01753 | 0.415 |
LIG_Pex14_2 | 159 | 163 | PF04695 | 0.274 |
LIG_Pex14_2 | 244 | 248 | PF04695 | 0.391 |
LIG_SH2_PTP2 | 80 | 83 | PF00017 | 0.295 |
LIG_SH2_SRC | 67 | 70 | PF00017 | 0.235 |
LIG_SH2_STAP1 | 241 | 245 | PF00017 | 0.464 |
LIG_SH2_STAP1 | 67 | 71 | PF00017 | 0.267 |
LIG_SH2_STAT5 | 140 | 143 | PF00017 | 0.428 |
LIG_SH2_STAT5 | 243 | 246 | PF00017 | 0.364 |
LIG_SH2_STAT5 | 80 | 83 | PF00017 | 0.295 |
LIG_SUMO_SIM_anti_2 | 73 | 80 | PF11976 | 0.356 |
LIG_TYR_ITIM | 78 | 83 | PF00017 | 0.308 |
LIG_WRC_WIRS_1 | 160 | 165 | PF05994 | 0.290 |
LIG_WRC_WIRS_1 | 194 | 199 | PF05994 | 0.382 |
LIG_WRC_WIRS_1 | 222 | 227 | PF05994 | 0.390 |
LIG_WRC_WIRS_1 | 245 | 250 | PF05994 | 0.315 |
MOD_CDC14_SPxK_1 | 166 | 169 | PF00782 | 0.338 |
MOD_CDK_SPxK_1 | 163 | 169 | PF00069 | 0.324 |
MOD_CK1_1 | 2 | 8 | PF00069 | 0.471 |
MOD_CK1_1 | 247 | 253 | PF00069 | 0.295 |
MOD_CK1_1 | 351 | 357 | PF00069 | 0.417 |
MOD_CK2_1 | 107 | 113 | PF00069 | 0.384 |
MOD_CK2_1 | 114 | 120 | PF00069 | 0.372 |
MOD_CK2_1 | 63 | 69 | PF00069 | 0.315 |
MOD_CK2_1 | 84 | 90 | PF00069 | 0.377 |
MOD_GlcNHglycan | 122 | 125 | PF01048 | 0.378 |
MOD_GlcNHglycan | 258 | 261 | PF01048 | 0.373 |
MOD_GlcNHglycan | 289 | 292 | PF01048 | 0.622 |
MOD_GlcNHglycan | 332 | 336 | PF01048 | 0.511 |
MOD_GlcNHglycan | 363 | 366 | PF01048 | 0.411 |
MOD_GSK3_1 | 155 | 162 | PF00069 | 0.402 |
MOD_GSK3_1 | 201 | 208 | PF00069 | 0.266 |
MOD_GSK3_1 | 244 | 251 | PF00069 | 0.359 |
MOD_GSK3_1 | 252 | 259 | PF00069 | 0.318 |
MOD_GSK3_1 | 268 | 275 | PF00069 | 0.337 |
MOD_GSK3_1 | 30 | 37 | PF00069 | 0.289 |
MOD_GSK3_1 | 50 | 57 | PF00069 | 0.139 |
MOD_GSK3_1 | 79 | 86 | PF00069 | 0.376 |
MOD_N-GLC_1 | 302 | 307 | PF02516 | 0.402 |
MOD_NEK2_1 | 11 | 16 | PF00069 | 0.366 |
MOD_NEK2_1 | 130 | 135 | PF00069 | 0.336 |
MOD_NEK2_1 | 159 | 164 | PF00069 | 0.400 |
MOD_NEK2_1 | 244 | 249 | PF00069 | 0.349 |
MOD_NEK2_1 | 256 | 261 | PF00069 | 0.370 |
MOD_NEK2_1 | 30 | 35 | PF00069 | 0.332 |
MOD_NEK2_1 | 316 | 321 | PF00069 | 0.324 |
MOD_NEK2_1 | 361 | 366 | PF00069 | 0.370 |
MOD_NEK2_2 | 221 | 226 | PF00069 | 0.445 |
MOD_NEK2_2 | 50 | 55 | PF00069 | 0.169 |
MOD_PIKK_1 | 316 | 322 | PF00454 | 0.461 |
MOD_PKA_1 | 155 | 161 | PF00069 | 0.418 |
MOD_PKA_2 | 155 | 161 | PF00069 | 0.418 |
MOD_PKA_2 | 348 | 354 | PF00069 | 0.374 |
MOD_Plk_1 | 227 | 233 | PF00069 | 0.423 |
MOD_Plk_1 | 296 | 302 | PF00069 | 0.556 |
MOD_Plk_4 | 114 | 120 | PF00069 | 0.286 |
MOD_Plk_4 | 130 | 136 | PF00069 | 0.287 |
MOD_Plk_4 | 155 | 161 | PF00069 | 0.431 |
MOD_Plk_4 | 244 | 250 | PF00069 | 0.319 |
MOD_Plk_4 | 252 | 258 | PF00069 | 0.365 |
MOD_Plk_4 | 30 | 36 | PF00069 | 0.294 |
MOD_Plk_4 | 348 | 354 | PF00069 | 0.392 |
MOD_ProDKin_1 | 108 | 114 | PF00069 | 0.392 |
MOD_ProDKin_1 | 163 | 169 | PF00069 | 0.509 |
MOD_ProDKin_1 | 248 | 254 | PF00069 | 0.409 |
MOD_SUMO_for_1 | 225 | 228 | PF00179 | 0.463 |
MOD_SUMO_rev_2 | 53 | 63 | PF00179 | 0.411 |
TRG_DiLeu_BaEn_1 | 333 | 338 | PF01217 | 0.361 |
TRG_DiLeu_LyEn_5 | 333 | 338 | PF01217 | 0.361 |
TRG_ENDOCYTIC_2 | 241 | 244 | PF00928 | 0.395 |
TRG_ENDOCYTIC_2 | 245 | 248 | PF00928 | 0.328 |
TRG_ENDOCYTIC_2 | 67 | 70 | PF00928 | 0.317 |
TRG_ENDOCYTIC_2 | 80 | 83 | PF00928 | 0.288 |
TRG_ER_diArg_1 | 154 | 156 | PF00400 | 0.346 |
TRG_Pf-PMV_PEXEL_1 | 212 | 216 | PF00026 | 0.518 |
TRG_Pf-PMV_PEXEL_1 | 336 | 340 | PF00026 | 0.377 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P740 | Leptomonas seymouri | 28% | 80% |
A0A0N1I5Z7 | Leptomonas seymouri | 69% | 100% |
A0A0N1I7E8 | Leptomonas seymouri | 38% | 98% |
A0A0S4IRH3 | Bodo saltans | 39% | 100% |
A0A0S4JVB2 | Bodo saltans | 24% | 90% |
A0A1X0NWZ0 | Trypanosomatidae | 27% | 76% |
A0A1X0NX10 | Trypanosomatidae | 43% | 99% |
A0A1X0NX22 | Trypanosomatidae | 41% | 79% |
A0A1X0NXP4 | Trypanosomatidae | 49% | 100% |
A0A3Q8IM07 | Leishmania donovani | 94% | 100% |
A0A3S7WXP2 | Leishmania donovani | 38% | 79% |
A0A3S7WXT7 | Leishmania donovani | 38% | 98% |
A4HCS3 | Leishmania braziliensis | 30% | 100% |
A4I097 | Leishmania infantum | 38% | 79% |
A4I0B8 | Leishmania infantum | 38% | 98% |
D4GP30 | Haloferax volcanii (strain ATCC 29605 / DSM 3757 / JCM 8879 / NBRC 14742 / NCIMB 2012 / VKM B-1768 / DS2) | 27% | 100% |
E9AH12 | Leishmania infantum | 94% | 85% |
E9AW61 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 30% | 100% |
E9AW82 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 40% | 98% |
O32223 | Bacillus subtilis (strain 168) | 26% | 100% |
P49305 | Rhizobium meliloti | 25% | 100% |
Q148L6 | Bos taurus | 25% | 100% |
Q4QBB6 | Leishmania major | 93% | 100% |
Q4QBB7 | Leishmania major | 30% | 100% |
Q7JK39 | Macaca fuscata fuscata | 25% | 100% |
Q9ALN5 | Saccharopolyspora spinosa | 27% | 100% |
Q9DBB8 | Mus musculus | 25% | 100% |
Q9SZ83 | Arabidopsis thaliana | 30% | 100% |
Q9TQS6 | Macaca fascicularis | 25% | 100% |
Q9TV69 | Sus scrofa | 23% | 100% |
Q9U0V7 | Leishmania major | 38% | 100% |
Q9UQ10 | Homo sapiens | 26% | 100% |
V5BB31 | Trypanosoma cruzi | 26% | 84% |
V5BH08 | Trypanosoma cruzi | 41% | 92% |